SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory and biopharma institutions globally.
Technology: Artificial Intelligence, Big Data, Bioinformatics, Biotechnology, Genetics, Health Care, Life Science, Medical
Industry: Early Drug Development
Headquarters: Boston, Massachusetts, United States
Founded Date: 2011-01-01
Employees Number: 251-500
Funding Status: IPO
Acquisitions Number: 1
Investors Number: 19
Total Funding: 250152150
Estimated Revenue: $50M to $100M
Last Funding Date: 2020-10-01
Last Funding Type: Series F

Visit Website
Register and Claim Ownership